Over the last decades significant advances have been made in the field of donor selection,
alternative transplant sources, immunosuppressive treatment and supportive care, as well …

Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of
chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to …

Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell
transplantation and a major cause of morbidity and mortality in affected patients. Especially …

Background Extracorporeal photopheresis (ECP) is an important cell‐based therapy for graft‐
versus‐host disease (GVHD); however, the blood volume required per treatment to achieve …

Extracorporeal photopheresis is effective treatment for chronic refractory graft-versus-host
disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Edelson et al. first reported the use of extracorporeal photopheresis (ECP) to treat cutaneous
T‐cell lymphoma (CTCL) in 1987, and since then several studies reporting response rates …

Extracorporeal photochemotherapy (ECP) has been shown to be effective in variety of
pathologic diseases such as Sezary syndrome, autoimmune diseases, organ graft rejection …

Since the first patient was treated with extracorporeal photochemotherapy (ECP) in 1978,
more than 150 ECP centers have emerged worldwide to deliver more than 200,000 ECP …

Extracorporeal photopheresis is an accepted method for the treatment of cutaneous T-cell
lymphoma and much progress has recently been achieved in therapy and understanding of …